Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Cancer Biomarkers: Enhancing Diagnostic, Therapeutic and Developmental Strategies' returned 3 results - Page 1 of 1  FEATURED RESULTS Antibody Drug Target Atlas in Oncology Cancer Diagnostic Testing World Markets Drug Delivery in Cancer - Technologies, Markets and Companies Anticancer Therapeutics Cancer and its Management, 6th Edition   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Biomarkers: Applications and Trends   Espicom Business Intelligence Ltd, Aug 2010, Pages: 138 While Biomarker research is still in its infancy, great strides have been made in the discovery and utilisation of biomarkers in the development of targeted cancer therapeutics and companion Commercial Opportunities from Biomarkers: Transforming drug discovery, clinical development and molecular diagnostics   Business Insights, May 2006, Pages: 206 in therapeutic areas other than cancer Vilazodone – case study Pharmacogenomic testing in the pharmaceutical industry – an update Conclusions Chapter 7 Biomarkers as surrogate endpoints Summary Introduction The Executive Guide to Molecular Imaging   Espicom Business Intelligence Ltd, July 2007, Pages: 306 , developmental, environmental, and therapeutic influences on gene products in the same animal or patient. But… - What will the impact of MI be on identification, tracking and treatment of diseases? - Why Results:  First -   Prev -   1 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets3    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network